| Authors: |
Pienta KJ; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Gorin MA; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland., Rowe SP; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland., Carroll PR; University of California San Francisco, San Francisco, California., Pouliot F; CHU de Quebec and Laval University, Quebec City, Quebec., Probst S; Jewish General Hospital, Montreal, Quebec., Saperstein L; Yale School of Medicine, New Haven, Connecticut., Preston MA; Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts., Alva AS; University of Michigan, Ann Arbor, Michigan., Patnaik A; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois., Durack JC; Memorial Sloan Kettering Cancer Center, New York, New York., Stambler N; Progenics Pharmaceuticals, Inc., New York, New York., Lin T; Progenics Pharmaceuticals, Inc., New York, New York., Jensen J; Progenics Pharmaceuticals, Inc., New York, New York., Wong V; Progenics Pharmaceuticals, Inc., New York, New York., Siegel BA; Mallinckrodt Institute of Radiology and Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri., Morris MJ; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York. |